Extending magnifying NBI diagnosis of intestinal metaplasia in the stomach: the white opaque substance marker
submitted 02 September 2016
accepted after revision 01 February 2017
10 April 2017 (eFirst)
Background and aims Intestinal metaplasia (IM) of the stomach is associated with an increased risk of differentiated gastric cancer. While it is important to diagnose IM endoscopically, it can be difficult to observe by white-light endoscopy. In magnifying endoscopy with narrow-band imaging (M-NBI) of the stomach, a light-blue crest (LBC) is widely known to be a useful marker in the endoscopic diagnosis of IM. However, IM that exhibits only white opaque substance (WOS) without an LBC can also occur. The aim of this study was to elucidate whether the presence of WOS on M-NBI of the stomach could serve as a marker of IM in the same way that an LBC does.
Methods The subjects were 40 consecutive patients who underwent M-NBI between July and December 2014. The primary endpoint in this study was to evaluate the diagnostic performance of M-NBI for histologically observed IM in WOS- and LBC-positive mucosa.
Results The sensitivity and specificity of WOS for histologically diagnosed IM were 50.0 % (95 % confidence interval [CI] 40.0 % – 50.0 %) and 100.0 % (95 %CI 85.0 % – 100.0 %), respectively. Meanwhile, the sensitivity and specificity of LBC were 62.5 % (95 %CI 51.1 % – 65.9 %) and 93.8 % (95 %CI 76.7 % – 98.9 %), respectively. The sensitivity and specificity of WOS and/or LBC (WOS positive and LBC positive, WOS positive and LBC negative, or WOS negative and LBC positive) for histologically diagnosed IM were 87.5 % (95 %CI 76.9 % – 90.9 %) and 93.8 % (95 %CI 77.9 % – 98.9 %), respectively.
Conclusions LBC and WOS are both useful markers for endoscopic diagnosis of IM. Combining both markers improves the sensitivity.
Clinical trial number: UMINCTR000014453.
- 1 Uemura N, Okamoto S, Yamamoto S. et al. Helicobacter pylori infection and the development of gastric cancer. NEJM 2001; 345: 784-789
- 2 Filipe MI, Potet F, Bogomoletz WV. et al. Incomplete sulphomucin-secereting intestinal metaplasia for gastric cancer. Preliminary data from a prospective study from three centers. Gut 1985; 26: 1319-1326
- 3 Rokkas T, Filipe MI, Sladen GE. et al. Detection of an increased incidence of early gastric cancer in patients with intestinal metaplasia type III who are closely followed up. Gut 1991; 32: 1110-1113
- 4 Sauerbruch T, Schreiber MA, Schüssler P. et al. Endoscopy in the diagnosis of gastritis. Diagnostic value of endoscopy criteria in relation to histological diagnosis. Endoscopy 1984; 16: 101-104
- 5 Uedo N, Ishihara R, Ishii H. et al. A new method of diagnosing gastric intestinal metaplasia: narrow-band imaging with magnifying endoscopy. Endoscopy 2006; 38: 819-824
- 6 Edoardo S, Marina C, Pietro D. et al. Narrow-band imaging with magnifying endoscopy is accurate for detecting gastric intestinal metaplasia. World J Gastroenterol 2013; 19: 2668-2675
- 7 Wang L, Huang W, Du J. et al. Diagnostic yield of the light blue crest sign in gastric intestinal metaplasia: a meta-analysis. PLoS One 2014; 9: e92874
- 8 Zhou Y, Zhou Z, Zhao J. et al. Application of narrow band imaging-magnifying endoscopy in surveillance of gastric mucosal intestinal metaplasia. Chin J Gastroenterol 2012; 1: 36-38
- 9 Saka A, Yagi K, Nimura S. OLGA- and OLGIM-based staging of gastritis using narrow-band imaging magnifying endoscopy. Dig Endosc 2015; 27: 735-742
- 10 Yao K, Iwashita A, Tanabe H. et al. White opaque substance within superficial elevated gastric neoplasia as visualized by magnification endoscopy with narrow-band imaging: a new optical sign for differentiating between adenoma and carcinoma. Gastrointest Endosc 2008; 68: 574-580
- 11 Yao K, Iwashita A, Nambu M. et al. Nature of white opaque substance in the gastric epithelial neoplasia as visualized by magnifying endoscopy with narrow-band imaging. Dig Endosc 2012; 24: 419-425
- 12 Ueo T, Yonemasu H, Yada N. et al. White opaque substance represents an intracytoplasmic accumulation of lipid droplets: Immunohistochemical and immunoelectron microscopic investigation of 26 cases. Dig Endosc 2013; 25: 147-155
- 13 Ueo T, Yonemasu H, Yao K. et al. Histologic differentiation and mucin phenotype in white opaque substance-positive gastric neoplasias. Endosc Int Open 2015; 3: E597-E604
- 14 Yao K, Iwashita A, Tanabe H. et al. Author’s reply to Letter to the Editor, “White opaque substance” and “light blue crest” within gastric flat tumors or intestinal metaplasia: same or different signs?. Gastrointest Endosc 2009; 70: 402-403
- 15 Bossuyt PM, Reitsma JB, Bruns DE. et al. Towards complete and accurate reporting of studies of diagnostic accuracy: the STRAD initiative. BMJ 2003; 4: 41-44
- 16 Yao K, Anagnostopoulos GK, Ragunath K. Magnifying endoscopy for diagnosing and delineating early gastric cancer. Endoscopy 2009; 41: 462-467
- 17 Kimura K, Takemoto T. An endoscopic recognition of the atrophic border and its significance in chronic gastritis. Endoscopy 1969; 3: 87-97
- 18 Hanaoka N, Uedo N, Siotani A. et al. Autofluorescence imaging for predicting development of metachronous gastric cancer after Helicobacter pylori eradication. J Gastroenterol Hepatol 2010; 25: 1844-1849